No Data
No Data
TOPPAN, Mitsui Sumitomo, Kddi Corporation, Square Enix HD (14th) (6005-9906)
※ The above Calendar is merely a plan and may be subject to change due to corporate circumstances.--------------------------------------- May 14 (Wed) <6005> Miura Factory <6013> Takuma <6027> Attorney Com <6061> Uniba Gardening <6063> EAJ <6069> Trends <6070> Career Link <6072> Ground Network H<
Express News | 【Change Report】 Mr. Akihiro Date reported a decrease in the shareholding ratio of Birdman (7063.JP) to 4.42%.
Kakaku.com ETC [Stocks with intriguing potential seen from Volume changes]
Closing price comparison with the previous day Volume * <9776> Sapporo 100,552,198,400 * <9240> Delivery Consultant 34,512,550,700 * <6074> JSS 41,514,134,400 * <6822> Oi Electric 273,219,884,000 * <3758> Aeria 25,124,654,400 * <4260> Hybrid Tech 46,769,202,300 * <7140> Petgo 89,129,135,400 * <4076> C.N.S 151,413,269,400 * <3
Express News | [Change Report] Akihiro Date reported a decrease in Shareholding in Birdman (7063.JP) to 5.46%.
Birdman ETC [Stocks with interesting features seen from Volume changes]
Closing price and changes from the previous day Volume * <7063> Birdman 2,316,718,200 * <149A> Shinka 1,074,150,153,700 * <3238> Central General 4,791,138,800 * <1560> Bursa KLCI 5,180,301,068 * <9561> Glad Cube 89,126,375,200 * <9791> Biken Tech 1,012,653,1900 * <8707> Iwai Koss Corp 256,049,353,200 * <9658> Bizi Tai Show 269,314,162,800
Individual stock information.
Kei Pharma <4896.T> is under a stop-high buy order. Keio University School of Medicine, which conducts joint research with the company, announced new research findings on regenerative medicine targeting subacute spinal cord injuries, one of the candidates in the development pipeline for regenerative medicine, on the weekend of the 21st. In the clinical study of regenerative medicine using iPS cell-derived neural progenitor cells, improvements were observed in two out of four patients. Saifuse <4892.T> Tokyo Stock Exchange is utilizing Margin Trading.
